The Cancer Journals

lung cancer risk factors can be dated to the 1990's is because this period was defined by an increased societal awareness to the adverse health effects of smoking tobacco. During the 1990's, over 40 states filed federal lawsuits against major American tobacco companies, and the growing involvement of the Surgeon General's office motivated many independent researchers to narrow their focus to lung cancer and its causes. Furthermore, this period of time saw the largest increases in lung cancer rates

Aim & Scope Recent Research in Oncology and Treatment is a medical journal that addresses to educate the health professionals and specialists about the standard, quality and value of care and development in science, and health services research to be provided to patients suffering from cancer. It is an Open access scholarly journal that publishes the outright and dependable source of knowledge and information on the discoveries, current developments and disclosure in the mode of Book Review, Case

Speech Title: Breast and Ovarian Cancer Purpose Statement: This speech has a primary goal of educating the audience and to give a better understanding of what breast cancer is and how it can be treated with detection by a vast variety of methods. It will also give better understanding that not only women but men also are susceptible to breast cancer. Introduction I. Attention: There are a number of researches done about breast and ovarian cancer. Breast cancer is the second largest cause of

Primarily focusing on oncology, the peer-reviewed journal Oncotarget also publishes work in the aging, immunology, microbiology, autophagy and cell death fields. Research papers receive a timely and unbiased peer review; Oncotarget also accepts reviews, case reports, editorials and news. Oncotarget publishes under a Creative Commons Attribution License, where the researcher's contribution to cancer research is recognized by redistribution, reuse and frequent frequent citations of his or her paper

regards to lung cancer treatment have been founded. Researchers have studies participants with a leading diagnosis of lung cancer, where the outcome was odd of treatment and where the outcome was reported by a measure of SEP (Socioeconomic Position). Further investigation is required to determine the patient, tumor, clinician, and system factors that may contribute to socioeconomic inequalities in receipt of lung cancer treatment. Although the incidence and outcome of lung cancer varies with socioeconomic

Dr. Hadley, Thank you for reading my discussion post. Pancreatic cancer is the fourth foremost trigger of cancer demise in the United States, the American Cancer Society projected that approximately 46,420 novel case of pancreatic cancer with about 39,590 demises in the United States (Reynolds and Folloder, 2014). According to Reynolds and Folloder (2014); Wolfgang et al., (2013), the lone treatment modality for pancreatic cancer with restorative potential is resection of the encompassed fraction

reference a certain part of texts. One of the main structure of a popular journal is being able to attract an audience to read their whole article. George Johnson, author of “Unraveling the Ties of Altitude, Oxygen and Lung Cancer” starts his article off by a great introduction. For example, “Epidemiologist have been puzzled by a strange pattern in their data: People living at higher altitudes appear less likely to get lung cancer” (Johnson). This introduction draws reader in who would like to learn

comorbid survivors of childhood cancer with the high psychosocial risk factors, in middle adolescence at the time of initial cancer diagnosis will be more like to display PTSD symptoms than other childhood cancer survivors. For the purpose of this research, long-term is defined as three plus years after completion of the cancer treatment. Comorbidity is defined as having either a secondary physical illness and/or a mental disorder diagnosed prior to the initial cancer diagnosis. Psychosocial risk

2010) . HER2 is a receptor protein that is a member of the epidermal growth factor receptor family and is over expressed in approximately 10-20% of breast cancers that have amplification of the HER2 gene (Jatoi, et al., 2010). Herceptin has been found to selectively apply anti-tumor effects in cancer models and patients with HER2+ breast cancer (Gajria & Chandarlapaty, n.d.). Although all normal breast cells present HER2 receptors on their surface, some cells may express more receptors, as high as

Applicants and Co-Applicants Dr Angeline Yek En Hui is a senior lecturer and cancer researcher at Newcastle University. Most of her publications in well-known journals such as Nature and Journal of Cancer are mainly centring the targeting therapies studies for cancers, mostly ovarian cancer and cervical cancer. Aiming to innovate new treatments for various cancers, she raised a team of 50 dedicated and responsible researchers and postgraduate students. In recent years, by the deep realizing and understanding